Kimid 2% Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective against a broad spectrum of dermatophytes, yeasts, and molds. It is indicated for the topical treatment of superficial fungal infections such as tinea corporis, tinea cruris, tinea pedis, and pityriasis versicolor, as well as seborrheic dermatitis. Ketoconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Kimid 2% Cream should be applied once or twice daily to the affected area after cleansing and drying the skin. The duration of treatment typically ranges from 2 to 4 weeks, depending on the severity and type of infection. Patients are advised to continue therapy for the full prescribed period, even if symptoms improve earlier, to prevent recurrence. Adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the application site. Kimid 2% Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any cream excipients. It is intended for external use only and should be kept away from eyes and mucous membranes. Consult a healthcare professional before use in pregnant or breastfeeding women.